287 related articles for article (PubMed ID: 14612852)
1. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
Boyle P; Diehm C; Robertson C
Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
[TBL] [Abstract][Full Text] [Related]
2. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
Beltramino R; Penenory A; Buceta AM
Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of a single daily dose of two capsules Cyclo 3 Fort in the morning versus a repeated dose of one capsule morning and noon. A one-month study.
Boccalon H; Causse C; Yubero L
Int Angiol; 1998 Sep; 17(3):155-60. PubMed ID: 9821028
[TBL] [Abstract][Full Text] [Related]
4. Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.
Aguilar Peralta GR; Arévalo Gardoqui J; Llamas Macías FJ; Navarro Ceja VH; Mendoza Cisneros SA; Martínez Macías CG
Int Angiol; 2007 Dec; 26(4):378-84. PubMed ID: 18091707
[TBL] [Abstract][Full Text] [Related]
5. Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
Allaert FA; Hugue C; Cazaubon M; Renaudin JM; Clavel T; Escourrou P
Int Angiol; 2011 Jun; 30(3):272-7. PubMed ID: 21617611
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
[TBL] [Abstract][Full Text] [Related]
7. An open-label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
Beltramino R; Penenory A; Buceta AM
Angiology; 2000 Jul; 51(7):535-44. PubMed ID: 10917578
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency--results of a double-blind placebo-controlled study.
Rabe E; Stücker M; Esperester A; Schäfer E; Ottillinger B
Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):540-7. PubMed ID: 21239190
[TBL] [Abstract][Full Text] [Related]
9. [Cyclo 3 fort--alternative in chronic venous insufficiency].
Stoianova V
Akush Ginekol (Sofiia); 2006; 45 Suppl 3():78-80. PubMed ID: 18240734
[No Abstract] [Full Text] [Related]
10. Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiency.
Boisseau MR
Int Angiol; 2002 Jun; 21(2 Suppl 1):33-9. PubMed ID: 12515978
[TBL] [Abstract][Full Text] [Related]
11. Use of extract of Ruscus aculeatus in venous disease in the lower limbs.
Cappelli R; Nicora M; Di Perri T
Drugs Exp Clin Res; 1988; 14(4):277-83. PubMed ID: 3048951
[TBL] [Abstract][Full Text] [Related]
12. Treatment of secondary lymphedema of the upper limb with CYCLO 3 FORT.
Cluzan RV; Alliot F; Ghabboun S; Pascot M
Lymphology; 1996 Mar; 29(1):29-35. PubMed ID: 8721977
[TBL] [Abstract][Full Text] [Related]
13. Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study).
Guex JJ; Avril L; Enrici E; Enriquez E; Lis C; Taïeb C
Int Angiol; 2010 Dec; 29(6):525-32. PubMed ID: 21173734
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
Andreozzi GM
Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
[TBL] [Abstract][Full Text] [Related]
15. [Chronic venous insufficiency: an open trial of FLEBS Crema].
Consoli A
Minerva Cardioangiol; 2003 Aug; 51(4):411-6. PubMed ID: 12900723
[TBL] [Abstract][Full Text] [Related]
16. New data on chronic venous disease: a new place for Cyclo 3® Fort.
Kakkos SK; Bouskela E; Jawien A; Nicolaides AN
Int Angiol; 2018 Feb; 37(1):85-92. PubMed ID: 29063748
[TBL] [Abstract][Full Text] [Related]
17. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
Flota-Cervera F; Flota-Ruiz C; Treviño C; Berber A
Angiology; 2008; 59(3):352-6. PubMed ID: 18388097
[TBL] [Abstract][Full Text] [Related]
19. [Controlled study of increasing venous tone in primary varicose veins by oral administration of Ruscus aculeatus and trimethylhespiridinchalcone].
Weindorf N; Schultz-Ehrenburg U
Z Hautkr; 1987 Jan; 62(1):28-38. PubMed ID: 3554800
[TBL] [Abstract][Full Text] [Related]
20. LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathy.
Cesarone MR; Belcaro G; Grossi MG; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Cacchio M
Minerva Cardioangiol; 2008 Oct; 56(5 Suppl):55-61. PubMed ID: 19597413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
